Ибупром

Quick links to important sections

Ибупром

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ибупром

Quick Facts About Ибупром

Property Description
Active ingredient Ibuprofen
Common forms Tablets, Capsules, Suspension, Gel
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Pain, fever, and inflammation relief
Origin Synthetic Propionic acid derivative

What Type of Medicine Is Ибупром? (Classification and Identity)

Ибупром is a trade name for a medicinal product whose sole active ingredient is Ibuprofen, a compound defined chemically as 2-(4-isobutylphenyl)propionic acid. The preparation is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification signifies that the compound acts to mitigate inflammation, fever, and pain without utilizing corticosteroids. Ibuprofen is a synthetic propionic acid derivative and is typically presented as a single-ingredient product, containing only Ibuprofen as the active substance. The product is frequently available for Over-the-Counter (OTC) access.


Composition and Available Forms of Ибупром (Entity Anatomy)

The fundamental composition relies on the active ingredient Ibuprofen, which is formulated for both systemic and localized administration. For the systemic oral route, Ибупром is commonly available in solid tablets, film-coated tablets, or soft capsules. For the topical route, the preparation is manufactured as a gel or other topical preparations, utilizing a suitable base to facilitate localized delivery. Various oral and dermal pharmaceutical forms are utilized for therapeutic application.


What Is the General Purpose of Ибупром? (Triple-Action Benefit)

The overall general purpose of Ибупром is to provide simultaneous relief from three core discomforts: pain, fever, and inflammation. This is achieved because the active component inherently delivers an Analgesic (pain-relieving), Antipyretic (fever-reducing), and Anti-inflammatory effect. Ibuprofen's efficacy in providing symptomatic relief is clinically recognized globally, helping to moderate the body's physical response to discomfort.

Regulatory References

  1. Ibuprofen and dexibuprofen-containing medicines - referral

What side effects are possible with Ибупром?

Possible Side Effects and Safety Information

Adverse reactions associated with Ibuprofen, the active ingredient in Ибупром, are formally classified by frequency and system-organ class in regulatory documentation. The safety profile highlights potential issues across the Gastrointestinal (GI), Cardiovascular (CV), Renal, and Nervous systems.

Regulatory Classification of Adverse Reactions

The most serious documented safety concerns are associated with the Nonsteroidal Anti-inflammatory Drug (NSAID) class as a whole. These include the risk of serious GI events, such as bleeding, ulceration, and perforation, and serious cardiovascular thrombotic events, including heart attack and stroke, which are stated to be potentially fatal.

Frequency Classification Examples of Documented Effects
Common (e.g., le 1 in 10) Dyspepsia, nausea, abdominal pain, headache, dizziness, fluid retention
Uncommon (e.g., le 1 in 100) Gastrointestinal ulceration, gastritis, hypersensitivity reactions
Very Rare (e.g., le 1 in 10,000) Severe allergic reactions (anaphylactic shock), severe skin reactions (SJS, TEN)

Safety Patterns and Special Populations

Official regulatory documents note that the risk of serious CV and GI events is generally increased with higher doses and longer duration of use. Gastrointestinal bleeding or ulceration may occur at any time during treatment, even without warning symptoms. Specific safety considerations are documented for certain populations: older adults are noted to have an increased frequency and severity of adverse reactions, particularly GI bleeding. Ibuprofen is formally contraindicated during the third trimester of pregnancy due to fetal risk. Furthermore, the product label documents that Ibuprofen may potentially decrease the antiplatelet effect of low-dose aspirin and should be used with caution in patients with pre-existing CV disease or renal impairment.

Overdose and Emergency Response

Overdose with Ibuprofen (Ибупром) is officially documented by regulatory authorities, with specific descriptions for symptoms and mandated emergency actions.

Manifestations & Complications Description
Documented Manifestations Initial presentations often include gastrointestinal upset (nausea, vomiting, abdominal pain) and central nervous system (CNS) effects such as drowsiness, lethargy, headache, and ringing in the ears (tinnitus).
Severe Outcomes Regulatory documents note the potential for life-threatening events, including convulsions (seizures), decreased level of consciousness leading to coma, acute renal failure, severe hypotension (shock), and metabolic acidosis. Severe gastrointestinal bleeding or perforation is also a risk.
Population Risk Notes Elderly patients (age 60 or older) are officially listed at greater risk for serious gastrointestinal adverse events. Ingestion levels for pediatric patients of 200 mg/kg or higher may necessitate clinical observation.

Required Emergency Actions and Management

Regulators explicitly mandate that if an overdose is suspected or known to have occurred, immediate medical attention must be sought. This involves calling the local emergency services or a Poison Control Center right away. Treatment is defined as symptomatic and supportive, as no specific antidote is known or available for Ibuprofen toxicity. Management protocols require monitoring of vital signs and laboratory tests to assess renal and hepatic function, with observation periods mandated following a significant ingestion.

Therapeutic Uses of Ибупром

What Ибупром Treats: Main Uses and Benefits

Ибупром (Ibuprofen) is commonly used across key therapeutic domains to provide supportive relief for symptoms related to physical discomfort, fever, and inflammation. The therapeutic scope is generally focused on symptomatic relief in conditions associated with acute or disruptive episodes, helping to address groups of symptoms that may appear suddenly or intensify over time.

The medication is commonly used when short-term symptomatic assistance is needed for indications such as headaches, dental pain, backache, muscular aches, menstrual cramps, joint swelling, and the fever and malaise associated with cold and flu symptoms. This supportive relief contributes to easing the overall symptom burden.


Easing Discomfort and Supporting Management of Inflammation

This medication is often used during phases when symptoms become more noticeable due to inflammatory or irritative states, such as in arthritis or after sprains and strains. Easing the discomfort and moderating the inflammatory process contributes to improved comfort during periods of heightened symptoms. The medicine is also commonly used to help with symptoms related to systemic imbalance, such as an elevated body temperature (fever), providing supportive relief when symptoms become more disruptive during flare-ups.


Quick Fact: Relief for Key Symptoms
Target Symptoms Pain, Fever, Inflammation, Swelling, Stiffness
Use Context Acute episodes, recurrent discomfort, injury-related pain
Patient Benefit Supports easing overall symptom load, assists with comfort
Core Action Provides symptomatic analgesic and antipyretic support

Eligibility and Restrictions for Use

Who Can and Cannot Use Ибупром (Ibuprofen)

The eligibility for Ибупром is strictly defined by regulatory documents, focusing on populations who must not use the medicine (contraindications) and those who require conditional use.

Absolute Contraindications

Use is strictly prohibited for individuals diagnosed with severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic failure. It is also contraindicated for patients with active or recurrent peptic ulcers, gastrointestinal bleeding, or a known hypersensitivity to Ibuprofen, Aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID). Furthermore, it must not be used for pain following Coronary Artery Bypass Graft (CABG) surgery.


Restricted and Conditional Use

The medicine's use is subject to age and health status limitations. Standard oral forms are not recommended for children under 12 years of age. Elderly patients are advised to use the lowest effective dose for the shortest duration due to increased risks. Use is contraindicated during the last trimester of pregnancy (from 30 weeks gestation). Patients with mild to moderate kidney or liver impairment, uncontrolled hypertension, or pre-existing conditions like Crohn's Disease must use the medicine only with caution and under restricted conditions.

What should I know about interactions with other medicines?

️ Interactions with other medicines and products

The official interaction profile for Ибупром (Ibuprofen), an NSAID, is structured around documented interactions that may alter drug exposure or result in additive pharmacodynamic risk, as described in government regulatory documents.


Documented Interaction Categories

Interaction Type Interacting Substances/Classes
Contraindicated Combinations Other NSAIDs (including COX-2 inhibitors)
Exposure Modification Lithium, Methotrexate, Digoxin, and CYP2C9 Inhibitors (e.g., Fluconazole)
Additive Risk (Pharmacodynamic) Oral Anticoagulants, Corticosteroids, SSRIs, Antiplatelet Agents
Efficacy Interference Diuretics, ACE Inhibitors, ARBs

Regulatory Constraints and Conditions

Co-administration with other NSAIDs is formally documented as contraindicated due to the enhanced risk of gastrointestinal (GI) and renal adverse effects. Regulatory documents state that Ibuprofen reduces the renal clearance of substances like Lithium and Methotrexate, leading to increased plasma concentrations and potential toxicity. Furthermore, the combination with oral anticoagulants heightens the documented risk of bleeding.

Specific timing separation is officially required for co-administration with low-dose, immediate-release Aspirin to prevent interference with its anti-platelet effect. The regulatory profile also notes that the risk of serious GI bleeding is increased when Ibuprofen is combined with alcohol or in vulnerable populations such as the elderly.

Mechanism of Action

The Core Action: Molecular Blockade of Cyclooxygenase

Ibuprofen (Ибупром) operates through a reversible, non-selective inhibition of the Cyclooxygenase (COX) enzymes, specifically affecting both COX-1 and COX-2 isoforms. The molecule competitively binds within the enzyme's active site, preventing the conversion of Arachidonic Acid into Prostaglandins and other Prostanoids. This initial molecular blockade determines the subsequent cascade of physiological effects.

Pathway Modulation and Systemic Effects

The resulting decrease in Prostaglandin E2 (PGE2) concentration modulates key signaling pathways centrally and peripherally. Peripherally, this reduction decreases the PGE2-mediated sensitization of nociceptors (pain-sensing nerve endings). Centrally, the effect modulates the hypothalamic thermal set point toward baseline. The action is modulatory and transient, restricted to reducing the output of PGE2-driven physiological reactions and does not alter the underlying pathology.

Dosage and Administration Information

Ибупром (Ibuprofen) is administered through official routes that include oral (tablets, capsules, suspension), topical, and intravenous (IV) infusion. The fundamental principle guiding its use, regardless of the route or form, is the administration of the lowest effective dose for the shortest duration necessary for symptomatic relief. The IV route is reserved for short-term clinical use when oral administration is not feasible, with a mandated transition to oral therapy as soon as possible.

For adults, oral dosing typically begins at 200 mg to 400 mg taken every 4 to 6 hours, dependent on symptom severity. The maximum daily dose for non-prescription use is 1200 mg, generally not to exceed six 200 mg units in 24 hours. Prescription regimens for inflammatory conditions may utilize doses of 400 mg to 800 mg per intake, extending up to a maximum of 3200 mg per day, administered in equally divided doses. Oral forms should generally be taken with food or milk to help mitigate gastrointestinal irritation. Non-prescription use is duration-constrained, typically limited to 3 days for fever or 10 days for pain.

Specific procedural rules dictate administration; for instance, intravenous solutions must be administered as an infusion over at least 30 minutes. For older adults, treatment should be initiated with the lowest effective dose, and dose reduction is typically required for patients with mild to moderate renal or hepatic impairment.

Recent Clinical Evidence

Ибупром: Recent Clinical Evidence

Ибупром contains ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) widely studied for its analgesic (pain-relieving), antipyretic (fever-reducing), and anti-inflammatory properties. Clinical evidence confirms its role in the management of mild to moderate pain and fever across various populations, including both adults and children over six months of age.

Efficacy in Acute Pain and Inflammation

Randomized controlled trials (RCTs) consistently report ibuprofen’s effectiveness in managing common acute conditions. High-quality evidence supports its use for:

  • Acute Pain: Effective relief for short-term pain such as headache (including tension-type headache and migraine), dental pain, and muscular aches.
  • Inflammatory Conditions: Demonstrated efficacy in reducing symptoms of inflammation, swelling, and stiffness associated with soft tissue injuries and inflammatory rheumatic diseases like osteoarthritis and rheumatoid arthritis.
  • Dysmenorrhea (Menstrual Pain): Research indicates it is a reliably effective treatment for primary menstrual cramps.

Comparative Performance and Safety Profile

Comparative studies suggest that the analgesic efficacy of ibuprofen is often comparable to other NSAIDs when used at similar therapeutic doses. At over-the-counter (OTC) doses, ibuprofen tends to be associated with a lower risk of gastrointestinal side effects compared to some older or more potent NSAIDs.

Research also addresses cardiovascular risk associated with NSAIDs. While all NSAIDs carry some risk, long-term observational data suggests that at the lower doses typically available over-the-counter, ibuprofen may present a comparatively lower risk of cardiovascular events than high-dose, long-term use of certain other NSAIDs, such as diclofenac. However, high-dose use (2,400 mg/day or more) warrants careful risk consideration, especially in patients with pre-existing heart conditions.

Frequently Asked Questions (FAQ)

Common questions about Ибупром (FAQ)


Q: What is the main difference between Ибупром and regular ibuprofen?

Ибупром is a brand name for a medicine whose active ingredient is ibuprofen. According to official labeling practices, the core therapeutic action and effects of the medicine are derived entirely from the ibuprofen component, which is a nonsteroidal anti-inflammatory drug (NSAID).


Q: Is Ибупром considered a strong painkiller?

Official prescribing information indicates that the active ingredient, ibuprofen, is used for the relief of mild to moderate pain. While different strengths are available—including higher doses that require a prescription—the overall classification of its analgesic effect remains within this range.


Q: Does Ибупром contain paracetamol?

The product Ибупром contains ibuprofen as its single active ingredient, which is an NSAID. Single-ingredient ibuprofen products, as described in their official composition, do not contain paracetamol, though other brand names may offer combination products.


Q: Is it possible to become dependent on Ибупром?

Official regulatory warnings for ibuprofen do not categorize it as a controlled substance, and it does not carry the formal warnings associated with dependency or addiction that are typically found on the labels of opioid medication.


Q: What are the signs of an allergic reaction to Ибупром?

Regulatory documents describe a severe allergic reaction to ibuprofen that may include hives, facial swelling, difficulty breathing (wheezing), severe skin reactions, or symptoms of shock. Official guidance indicates that if these symptoms are experienced, medical help should be sought immediately.


Q: Is there any difference between the various forms of Ибупром (e.g., tablets, capsules)?

Different pharmaceutical forms of ibuprofen, such as tablets and capsules, are available. Official clinical pharmacology information notes that forms like liquid-filled capsules may be absorbed more quickly by the body than standard tablets, but the overall amount of drug absorbed is generally similar.


Q: Can Ибупром be used for a migraine headache?

Yes, official regulatory labels for some formulations of the active ingredient, ibuprofen, indicate its use for the temporary relief of pain. This use includes the pain associated with various types of headaches, which may specifically include migraine pain.


Q: Are there specific food or drinks that should be avoided when taking Ибупром?

The official product warnings highlight alcohol as a substance to be avoided, stating that combining it with ibuprofen increases the documented risk of serious stomach bleeding. Beyond this, regulatory guidance generally does not require the avoidance of specific foods.


Q: Why is it said that some people with heart conditions should avoid Ибупром?

Regulatory warnings indicate that NSAIDs like ibuprofen can increase the documented risk of serious cardiovascular thrombotic events, such as heart attack and stroke. Therefore, official contraindications include use after coronary artery bypass graft (CABG) surgery and for patients with severe heart failure.


Q: Is it possible for Ибупром to cause drowsiness?

Official regulatory documents list side effects affecting the nervous system, such as dizziness and headache. While drowsiness itself is not always listed as a common side effect, these related central nervous system effects are documented in official safety information.


Q: Can Ибупром be taken by people who are already taking medication for anxiety?

Ibuprofen is not documented to have a major interaction with all anxiety medications. However, official interaction profiles warn that certain classes of antidepressants, specifically SSRIs, may increase the documented risk of gastrointestinal bleeding when co-administered with ibuprofen.


Q: What happens if I miss the time I usually take Ибупром?

Official directions advise patients that if a dose is missed, it should be taken as soon as it is remembered. If it is almost time for the next dose, official directions typically advise skipping the missed dose and continuing with the regular schedule, rather than taking two doses simultaneously.


Q: Why do some packages mention different strengths for Ибупром?

Ibuprofen is manufactured in multiple strengths, which is consistent with regulatory standards. Lower strengths are commonly available over-the-counter, whereas higher strengths are reserved for prescription use to manage more severe pain and inflammation.


Q: Is there a link between taking Ибупром and experiencing tinnitus (ringing in the ears)?

Yes, official regulatory documentation lists tinnitus (ringing in the ears) as an uncommon side effect. This indicates it is a recognized, though not frequent, adverse reaction associated with the use of ibuprofen.


Q: Does Ибупром interact with blood thinners?

According to official interaction documents, ibuprofen does interact with medications commonly referred to as 'blood thinners.' Specifically, it increases the documented risk of bleeding when used with oral anticoagulants and may interfere with the antiplatelet effect of low-dose aspirin.


Q: Is it true that taking Ибупром can sometimes mask symptoms of a serious infection?

The fever-reducing and pain-relieving effects of the active ingredient are noted in regulatory guidance. The effect may potentially obscure symptoms that a healthcare professional would use to assess the presence and severity of an infection.


Q: Is the action of Ибупром similar to other NSAIDs?

Yes. Ibuprofen is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Its action is similar to other drugs in this class because it works by inhibiting cyclooxygenase (COX) enzymes, which are central to the body's pain and inflammation pathways.


Q: Are there any specific lifestyle factors mentioned in the official guidance for people taking Ибупром?

The most significant lifestyle factor explicitly highlighted in regulatory warnings is the consumption of alcohol. Combining alcohol with ibuprofen significantly increases the documented risk of serious adverse effects, specifically gastrointestinal bleeding.


Q: How is the safety of Ибупром monitored after it is made available?

After the drug is made available to the public, its safety is continually monitored through post-market surveillance programs. Regulatory authorities like the FDA and EMA run systems to track and review reports of side effects and emerging safety issues.


Q: Is it possible to take another pain reliever at the same time as Ибупром?

Official warnings strongly advise against using ibuprofen with other pain relievers that are also NSAIDs (like naproxen or high-dose aspirin), as this significantly increases the risk of side effects. However, the label does not prohibit the use of non-NSAID pain relievers.


Q: How quickly does Ибупром start working after taking it?

Official clinical pharmacology information indicates that the active ingredient, ibuprofen, is rapidly absorbed by the body. Peak serum levels are typically reached within one to two hours after taking an oral dose, which aligns with the time frame for when patients may begin to feel relief.


Q: What is the typical length of time the effect of Ибупром lasts?

The duration of ibuprofen's effect is generally consistent with the recommended dosing interval. This interval is typically specified in official directions as being every four to six hours to maintain therapeutic action.


Q: Is it necessary to take Ибупром with food?

Official patient information often advises taking oral forms of ibuprofen with food or milk, which is noted to help mitigate the risk of gastrointestinal irritation, such as stomach upset or dyspepsia.


Q: Does the official patient information for Ибупром contain information on pregnancy and breastfeeding?

Yes, official regulatory documents contain information and warnings for both. Ibuprofen is formally contraindicated during the third trimester of pregnancy due to potential fetal risks, and use during breastfeeding is also addressed in the labels.


Q: Can taking Ибупром affect my blood pressure?

Official warnings state that NSAIDs like ibuprofen can potentially cause the onset of new high blood pressure or worsen existing high blood pressure. Patients with existing hypertension are advised to use the medication with caution due to this documented effect.


Q: What information is available regarding the long-term use of Ибупром?

Regulatory warnings emphasize that the risk of serious side effects—particularly cardiovascular and gastrointestinal events—is documented to increase with higher doses and longer duration of use. Non-prescription use is typically restricted to short-term symptomatic relief.


Q: What are the most common reasons people report stopping the use of Ибупром?

While regulatory documents do not list 'reasons for stopping,' the most common documented side effects that lead to patient concern are those related to the gastrointestinal system. These effects include dyspepsia, nausea, and abdominal pain.


Q: Is it considered normal for Ибупром to sometimes cause mild heartburn?

Yes, mild gastrointestinal effects are common. The official documents list dyspepsia (a term for indigestion that can include heartburn) and abdominal pain as common side effects associated with the use of ibuprofen.


Q: Can İbuprofen be crushed or cut, or should it be swallowed whole?

For standard immediate-release tablets, there are generally no explicit regulatory warnings against splitting. However, forms labeled as extended-release or enteric-coated should not be crushed or split, as this can interfere with the designed release of the active ingredient.


Q: Does the effect of Ибупром change if it is taken with alcohol?

Official labels and warnings focus heavily on the documented safety risk, which is that combining ibuprofen with alcohol significantly increases the risk of serious gastrointestinal bleeding. The focus is on safety rather than a change in the drug's therapeutic effect.

How should Ибупром be stored and disposed of?

How to Store and Dispose of Ибупром?

The official storage and disposal requirements for Ибупром (Ibuprofen) are defined by regulatory labeling to maintain product stability and ensure public safety.


Official Storage Requirements

  • Temperature and Container: Store the product at controlled room temperature, typically below 25 C (77 F), and always keep it in its original, tightly closed container to protect it from moisture.
  • Child Safety: It is mandatory to keep this medicine out of the sight and reach of children at all times.

Official Disposal Instructions

  • Unused Product: Unused or expired medication must be disposed of according to local pharmaceutical regulations. The preferred method is using an official drug take-back program.
  • Environmental Constraint: Regulatory guidelines strictly advise against flushing the product down the toilet or disposing of it in wastewater, unless the product labeling specifically instructs otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ибупром found in:

A-Z Index: